AAAAAA

   
Results: 1-8 |
Results: 8
REPORT OF THE NIH PANEL TO DEFINE PRINCIPLES OF THERAPY OF HIV-INFECTION
Authors: CARPENTER C FEINBERG M AUBRY W AVERITT D COFFIN J COOPER D FOLLANSBEE S HAMBURG P HARRINGTON M HIDALGO J JAFFE H LANDERS D MASUR H PIZZO P RICHMAN D SAAG M SCHOOLEY R STONE V THOMPSON M TRONO D VELLA S WALKER B YENI P
Citation: C. Carpenter et al., REPORT OF THE NIH PANEL TO DEFINE PRINCIPLES OF THERAPY OF HIV-INFECTION, Annals of internal medicine, 128(12), 1998, pp. 1057-1078
PILOT-STUDY OF TOPICAL TRIFLURIDINE FOR THE TREATMENT OF ACYCLOVIR-RESISTANT MUCOCUTANEOUS HERPES-SIMPLEX-DISEASE IN PATIENTS WITH AIDS (ACTG-172)
Authors: KESSLER HA HURWITZ S FARTHING C BENSON CA FEINBERG J KURITZKES DR BAILEY TC SAFRIN S STEIGBIGEL RT CHEESEMAN SH MCKINLEY GF WETTLAUFER B OWENS S NEVIN T KORVICK JA VALENTINE F DEHOLCZER L WEAVER D POTTAGE J URBANSKI P BARTLETT JG BECKER R REXROAD V SCHOOLEY R RAY G POWDERLY W GOULD M ROYAL M CALO J COLEMAN R MARIUZ P WEISSMAN E BURK RA AVATO J MANGINI L GRIECO M
Citation: Ha. Kessler et al., PILOT-STUDY OF TOPICAL TRIFLURIDINE FOR THE TREATMENT OF ACYCLOVIR-RESISTANT MUCOCUTANEOUS HERPES-SIMPLEX-DISEASE IN PATIENTS WITH AIDS (ACTG-172), Journal of acquired immune deficiency syndromes and human retrovirology, 12(2), 1996, pp. 147-152
THE SAFETY AND ANTIVIRAL EFFECT OF 1592U89, ALONE AND IN COMBINATION WITH ZIDOVUDINE IN HIV-1-INFECTED PATIENTS WITH CD4-500 CELLS( COUNTS 200)MM(3)/
Authors: SONNERBORG A LANCASTER D TORRES R THOMPSON M SAAG M SCHOOLEY R MULDER J GAZZARD B DAQUILA R GURGUL M FEINBERG J SANTIN M LANG W HARRIGAN PR STEEL H TORTELL S ROMERO C
Citation: A. Sonnerborg et al., THE SAFETY AND ANTIVIRAL EFFECT OF 1592U89, ALONE AND IN COMBINATION WITH ZIDOVUDINE IN HIV-1-INFECTED PATIENTS WITH CD4-500 CELLS( COUNTS 200)MM(3)/, AIDS, 10, 1996, pp. 41-41
CONSENSUS CONFERENCE ON LABORATORY MARKERS IN HIV-INFECTION - CONSENSUS CONCLUSIONS
Authors: AIUTI F BOUCHER C DIANZANI F FENYO EM HO D LANE C LANGE J MONTANER J PANTALEO G PERRIN L ROMAGNANI S SAAG M SCHOOLEY R VELLA S
Citation: F. Aiuti et al., CONSENSUS CONFERENCE ON LABORATORY MARKERS IN HIV-INFECTION - CONSENSUS CONCLUSIONS, Journal of biological regulators and homeostatic agents, 9(3), 1995, pp. 119-120
CD4 COUNTS AS SURROGATE MARKERS FOR PROGRESSION TO AIDS - RESPONSE
Authors: CHOI SS LAGAKOS S SCHOOLEY R
Citation: Ss. Choi et al., CD4 COUNTS AS SURROGATE MARKERS FOR PROGRESSION TO AIDS - RESPONSE, Annals of internal medicine, 120(1), 1994, pp. 88-88
LIPOSOME UPTAKE BY HUMAN PRIMARY LYMPHOBLASTS
Authors: SULLIVAN S AYERS D CAMPBELL T KURITZKES D SHERRER J SCHOOLEY R
Citation: S. Sullivan et al., LIPOSOME UPTAKE BY HUMAN PRIMARY LYMPHOBLASTS, Journal of cellular biochemistry, 1993, pp. 23-23
ANTIRETROVIRAL AND IMMUNE-BASED THERAPIES - UPDATE
Authors: YENI P SCHOOLEY R HAMMER S
Citation: P. Yeni et al., ANTIRETROVIRAL AND IMMUNE-BASED THERAPIES - UPDATE, AIDS, 7, 1993, pp. 190000173-190000184
STATUS OF IMMUNE-BASED THERAPIES IN HIV-INFECTION AND AIDS
Authors: FAHEY JL SCHOOLEY R
Citation: Jl. Fahey et R. Schooley, STATUS OF IMMUNE-BASED THERAPIES IN HIV-INFECTION AND AIDS, Clinical and experimental immunology, 88(1), 1992, pp. 1-5
Risultati: 1-8 |